- Home
- Applications
- canada alberta
- heart attack
Refine by
Heart Attack Product Applications Available In Alberta
15 applications found
Increased Efficiency; Use SmartHeart to reduce time spent performing ECGs and redirect valuable labor to increase ...
BySmartHeart based in Hauppauge, NEW YORK (USA)
Arterial stiffness is a significant concern in sport medicine, as it can have implications for the health and performance of athletes. Elevated arterial stiffness in athletes can lead to decreased blood flow and oxygen delivery to the muscles, as well as an increased risk of cardiovascular events such as heart attack and stroke. As a result, understanding and managing arterial stiffness is an important part of the care of athletes in sport ...
ByTensiomed based in Budapest, HUNGARY
Heart Failure may start suddenly, and you may feel symptoms immediately, or it may start slowly and progress unnoticed for some time. Some patients do not realize that they have heart failure because they believe that their symptoms are just indications of getting older. The condition typically starts after there is some sort of injury to the heart muscle (e.g. a heart attack), and over time, the unusual stresses placed on the heart muscle cause the disease to progressively ...
ByImpulse Dynamics based in Marlton, NEW JERSEY (USA)
Misdiagnosed Myocardial Ischemia, Heart Attack & Stroke Risk Leads to Poor Outcomes; Myocardial ischemia occurs when blood flow to your heart is reduced, preventing the heart muscle from receiving enough oxygen. This is often the result of plaque buildup inside the artery wall. Heart attack and stroke are primarily caused by non-obstructive, but unstable plaque in the arteries that goes undiagnosed and untreated.1 Current non-invasive testing cannot visualize the biology deep inside artery walls where heart ...
ByElucid based in Boston, MASSACHUSETTS (USA)
CleveMed's sleep monitoring devices can aid in sleep apnea diagnosis only when prescribed by a doctor, and cannot be sold directly to patients as per FDA regulations. ...
ByCleveland Medical Devices Inc. based in Cleveland, OHIO (USA)
Ventricular Tachycardia (VT) is a complex condition that has many underlying causes, varying degrees of symptoms, and potentially fatal outcomes if not treated effectively. ...
ByThermedical, Inc. based in Waltham, MASSACHUSETTS (USA)
Rapid genotyping for antiplatelet therapy. 1 in 3 people carry mutations. 30 percent of Caucasians and 40 percent of Asians carry CYP2C19 mutations that impair drug metabolism. For heart attack patients, most complications from poor Plavix® response occur in the first 24 to 48 hours after cardiac stenting. ...
ByGenomadix based in Ottawa, ONTARIO (CANADA)
Diabetes is one of the top health issues facing the world today. 422 million people suffer from diabetes worldwide (8.5% of the world population) of which an estimated 29 million are in the US. Of the three types of diabetes (Type 1, Type 2, and gestational), Type 2 accounts for over 90% of the total cases of diabetes. The increased prevalence of diabetes and obesity (a risk factor for Type 2 diabetes) has increased dramatically from 1994 to 2014 and is expected to grow. There are 86 million Americans with ...
ByAlertgy based in Melbourne, FLORIDA (USA)
Traditionally, primary treatment for DVT has focused on anticoagulation, rather than thrombus removal. Anticoagulation therapy does not remove existing thrombus but rather prevents the propagation of the ...
BySurmodics, Inc. based in Eden Prairie, MINNESOTA (USA)
Endovascular clot removal methods can provide immediate symptom relief and, by removing clot early, physicians can identify an underlying obstructive lesion that may require a stent. Current endovascular treatment methods involve catheter-directed thrombolysis (CDT), percutaneous mechanical thrombectomy (PMT), balloon venoplasty, iliac vein stenting, and manual ...
BySurmodics, Inc. based in Eden Prairie, MINNESOTA (USA)
Heart failure is a chronic condition in which the heart is no longer able to adequately pump blood to meet the demands of the body. It is the progressive weakening of the heart that may impact the function of multiple organs presented as a collection of symptoms. In acute heart failure, the onset of heart failure symptoms and progressive decline can occur rapidly over a short period of ...
ByEvaheart, Inc. (EVI) based in Houston, TEXAS (USA)
Our flagship products, Virtue SAB and BackBeat CNT, have the potential to improve clinical outcomes and provide distinct commercial advantages within two of the largest and most well-established global medical device ...
ByOrchestra BioMed, Inc. based in New Hope, PENNSYLVANIA (USA)
Whether you have trouble falling asleep, wake up throughout the night, or just feel tired in the morning, meditation for sleep can help relax your mind and body at bedtime and improve your overall quality of ...
ByInteraXon Inc. based in Toronto, ONTARIO (CANADA)
Coronary artery disease (CAD), also known as coronary heart disease, is the most common form of cardiovascular disease and the number one cause of death in the United States and Europe. According to the American Heart Association, CAD affects over 13 million Americans and accounts for over 650,000 deaths ...
ByQT Vascular Ltd. based in , SINGAPORE
ViTrack is a platform technology with applications across the continuum of care. In 2015, with the support of MIT and Tufts, the founding team behind Dynocardia began their search for a fundamentally different approach to the measurement of blood pressure (BP) that can measure automatically, without the participation of the user, caregiver, or healthcare provider. After rigorous bench testing and ongoing clinical studies in the ICU, ViTrack technology is proven to offer accurate continuous, non-invasive blood ...
ByDynocardia, Inc. based in Cambridge, MASSACHUSETTS (USA)